106 related articles for article (PubMed ID: 1430968)
1. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
3. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
[TBL] [Abstract][Full Text] [Related]
5. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
Cheasty T; Day M; Threlfall EJ
Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
Datta P; Sen D
Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
[TBL] [Abstract][Full Text] [Related]
9. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
Salam MA; Bennish ML
J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
[TBL] [Abstract][Full Text] [Related]
10. Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.
Bhattacharya MK; Bhattacharya SK; Paul M; Dutta D; Dutta P; Kole H; De D; Ghosh AR; Das P; Nair GB
J Diarrhoeal Dis Res; 1994 Jun; 12(2):121-4. PubMed ID: 7963341
[TBL] [Abstract][Full Text] [Related]
11. Response to antimicrobial therapy for shigellosis in Thailand.
Lolekha S; Vibulbandhitkit S; Poonyarit P
Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
[TBL] [Abstract][Full Text] [Related]
13. Nalidixic acid in resistant shigella infection.
Agrawal ML; Mukherjee SP; Prasad SS
J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
[No Abstract] [Full Text] [Related]
14. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
[TBL] [Abstract][Full Text] [Related]
15. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
Islam MR; Alam AN; Hussain MS; Mahalanabis D
J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.
Yunus M; Mizanur Rahman AS; Farooque AS; Glass RI
J Trop Med Hyg; 1982 Oct; 85(5):195-9. PubMed ID: 6757458
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
Haltalin KC; Nelson JD; Kusmiesz HT
Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
Lolekha S; Patanachareon S; Thanangkul B; Vibulbandhitkit S
Scand J Infect Dis Suppl; 1988; 56():35-45. PubMed ID: 3074464
[TBL] [Abstract][Full Text] [Related]
19. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
Hansson HB; Barkenius G; Cronberg S; Juhlin I
Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
[TBL] [Abstract][Full Text] [Related]
20. International note. Antibiotics in the management of shigellosis.
Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
